Aug 20, 2021, 11:51 AM by

Biofourmis completed a proof of concept study for its heart failure digital therapeutic BiovitalsHF that met its endpoint of number of patients at 50% of optimal therapy. As a result, FDA has granted the DTx the first-ever Breakthrough Designation for a heart failure digital therapy.

Aug 20, 2021, 11:51 AM by

Deep longitudinal, disease agnostic structured global dataset, covering over 4,000 indications will industrialize Sensyne’s life sciences activities

Aug 20, 2021, 11:51 AM by

Positive Technologies researchers discovered a vulnerability in Cisco Firepower Device Manager On-Box – a product designed to locally configure Cisco Firepower firewalls. Now patched, the flaw could allow attackers to gain full control over the device and its capabilities. That could include handing over to criminals the ability to filter traffic. Attackers could also shut down a firewall, or even access other internal resources within an enterprise, if they’re located on the same subnet.

Aug 20, 2021, 11:43 AM by

Advanced Instruments, a leading manufacturer of analytical instruments and services for bioprocessing, today announced the execution of a definitive agreement to acquire Solentim, a trusted global leader of solutions for the isolation and characterization of high value single cell clones in cell line development (CLD) applications.

Aug 20, 2021, 11:43 AM by

Aug 20, 2021, 11:43 AM by

Aug 20, 2021, 11:43 AM by

Amerigo Scientific recently launches AcrB transporter that aids in the identification, development, refinement, and validation of new molecules and therapeutic antibodies.

Aug 20, 2021, 11:41 AM by

DNAnexus platform exceeds online security policy objectives outlined in President Biden’s executive order protecting American infrastructure from cyberattacks

Aug 20, 2021, 11:41 AM by

FDB Launches Clinical Decision Support Analytics Solution

Aug 20, 2021, 11:41 AM by

Lightbeam Health Solutions Announces Partnership with Genetic Testing Company, Ambry Genetics

Aug 20, 2021, 11:41 AM by

Heraeus Pharmaceutical Ingredients’ additional production line for Platinum-based highly potent active pharmaceutical ingredients (Pt hAPIs) is now fully operational at the company’s headquarters in Hanau, Germany.

Aug 20, 2021, 11:41 AM by

For further information on Dotmatics, please visit www.dotmatics.com

Aug 20, 2021, 11:41 AM by

Quanticate, a leading global data-focused Clinical Research Organization (CRO), has named Piotr Karasiewicz as the company's new Head of Machine Learning and Digital Transformation to lead process improvements and ensure efficient and high-quality data analysis.

Aug 20, 2021, 11:40 AM by

Aug 20, 2021, 11:40 AM by

Many cancer clinical research trials were put on hold during Covid – now Panthera Biopartners and Rutherford Health are working in partnership to accelerate oncology research in order to provide improved care for patients.

Aug 20, 2021, 11:40 AM by

Ashfield Engage, part of UDG Healthcare plc, announced that it has partnered with ADVANZ PHARMA to develop and deliver a pan-European talent acquisition programme for ADVANZ PHARMA’s specialty medicine division.

Aug 20, 2021, 11:40 AM by

Researchers will be able to make faster and more accurate analysis of experiment data with a workflow powered by Qlucore Omics Explorer and MetaCore™, a Cortellis™ solution.

Aug 20, 2021, 11:40 AM by

StageZero Life Sciences, the company that created the first-ever test that simultaneously screens for multiple cancers from a single sample of blood, has acquired Care Oncology. Care Oncology has clinics in California, telehealth practices in all 50 states and provides treatments that complement and enhance the effect of standard-of-care cancer therapies. This acquisition expands StageZero’s clinical offerings, including access to a robust network of oncologists and physicians across the U.S.

Aug 20, 2021, 11:40 AM by

Partek® Flow® bioinformatics software to be integrated into Agilent Alissa Clinical Informatics Platform to deliver a complete end-to-end analysis.

Aug 20, 2021, 11:40 AM by